Form 4: Intuitive Surgical CEO's Stock Transactions

David J. Rosa, CEO of Intuitive Surgical Inc., reported transactions involving the acquisition and disposition of common stock and restricted stock units.

Summary

• David J. Rosa, Chief Executive Officer and Director of Intuitive Surgical Inc. (ISRG), reported transactions on June 10, 2026.
• He acquired 1,358 shares of common stock with a transaction code 'M' at a price of $0.0, resulting in 246,567 shares beneficially owned.
• Additionally, 674 shares were disposed of with a transaction code 'F' at a price of $426.61, leaving 245,893 shares beneficially owned.
• The filing also details Restricted Stock Units (RSUs) where 25% vest annually over four years from the grant date of June 10, 2023.
• A portion of the vested shares were held back to cover tax withholding requirements.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it represents routine stock transactions by an executive, including both acquisitions (likely compensation) and dispositions.

Positives

• CEO David J. Rosa continues to hold a significant number of Intuitive Surgical shares, indicating confidence in the company.
• The acquisition of 1,358 shares at $0.0 suggests these were likely part of a stock-based compensation award, aligning management incentives with company performance.

Negatives

• The disposition of 674 shares at $426.61 per share represents a sale of company stock by a key executive.

Risks

• While not explicitly stated as a risk in this filing, executive stock sales can sometimes be interpreted negatively by the market, potentially impacting share price if not contextualized by other factors.
• The reliance on stock-based compensation (RSUs) means a portion of executive compensation is tied to the company's stock performance, which inherently carries market risk.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance. However, the vesting schedule of RSUs implies continued equity awards tied to service over the next few years.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for executive and director stock transactions. For a company like Intuitive Surgical, a leader in robotic-assisted surgery, such filings are closely watched for insights into insider confidence and potential market signals.

Comparison to Industry Standards

• This filing is a standard SEC Form 4, which is a regulatory requirement for all publicly traded companies in the U.S. to report changes in beneficial ownership by insiders.
• The structure of the RSU vesting (25% per year over four years) is a common practice in the technology and healthcare sectors, aligning with industry standards for executive compensation.

Stakeholder Impact

• Shareholders: The sale of shares by the CEO could be perceived as a minor negative signal, though the context of RSU vesting and tax withholding mitigates this.
• Employees: The continued vesting of RSUs reinforces the company's use of equity-based compensation to retain talent.
• Management: The transactions reflect standard executive compensation and personal financial management practices.

Next Steps

• Continued vesting of RSUs over the next three years, subject to continued service.
• Potential future stock transactions by David J. Rosa as RSUs vest and as per his personal financial planning.

Key Dates

Keywords

Intuitive Surgical, ISRG, Form 4, Stock Transaction, Insider Trading, CEO, Restricted Stock Units, RSU Vesting, Beneficial Ownership, SEC Filing